BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 153 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,836 | -32.8% | 6,000 | +7.5% | 0.00% | – |
| Q2 2023 | $123,259 | +5.3% | 5,579 | +3.6% | 0.00% | – |
| Q1 2023 | $117,088 | +34.6% | 5,386 | +12.5% | 0.00% | – |
| Q4 2022 | $87,000 | -29.3% | 4,788 | -11.9% | 0.00% | – |
| Q3 2022 | $123,000 | +78.3% | 5,435 | +7.7% | 0.00% | – |
| Q2 2022 | $69,000 | -33.7% | 5,046 | +10.2% | 0.00% | – |
| Q1 2022 | $104,000 | -82.2% | 4,577 | -70.8% | 0.00% | -100.0% |
| Q4 2021 | $585,000 | -24.1% | 15,700 | -13.9% | 0.00% | -50.0% |
| Q3 2021 | $771,000 | +5.3% | 18,232 | +10.9% | 0.00% | 0.0% |
| Q2 2021 | $732,000 | +275.4% | 16,433 | +201.5% | 0.00% | – |
| Q1 2021 | $195,000 | -86.3% | 5,451 | -84.7% | 0.00% | -100.0% |
| Q4 2020 | $1,426,000 | +15744.4% | 35,741 | +11618.4% | 0.00% | – |
| Q3 2020 | $9,000 | -57.1% | 305 | -76.6% | 0.00% | – |
| Q2 2020 | $21,000 | +600.0% | 1,305 | +327.9% | 0.00% | – |
| Q1 2020 | $3,000 | – | 305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,780,000 | $107,441,800 | 11.89% |
| Gagnon Advisors, LLC | 360,758 | $4,982,067 | 4.17% |
| Meros Investment Management, LP | 372,203 | $5,140,123 | 2.80% |
| Park West Asset Management LLC | 2,014,954 | $27,826,515 | 2.56% |
| GAGNON SECURITIES LLC | 633,363 | $8,746,743 | 2.19% |
| Mesirow Financial Investment Management, Inc. | 26,710 | $368,865 | 1.60% |
| Roubaix Capital, LLC | 146,898 | $2,028,661 | 1.50% |
| Millrace Asset Group, Inc. | 48,917 | $676 | 0.84% |
| Soleus Capital Management, L.P. | 439,000 | $6,062,590 | 0.56% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,363,638 | $18,831,841 | 0.53% |